🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/10/1974 | 1,63 | 1,65 | 1,55 | 1,57 | -3,66% | 5,90% | 3.848.256 |
| 15/10/1974 | 1,61 | 1,65 | 1,59 | 1,63 | +1,44% | 3,92% | 2.358.000 |
| 14/10/1974 | 1,58 | 1,64 | 1,58 | 1,61 | +1,89% | 3,35% | 1.626.077 |
| 11/10/1974 | 1,52 | 1,61 | 1,50 | 1,58 | +3,93% | 6,99% | 2.697.552 |
| 10/10/1974 | 1,48 | 1,56 | 1,48 | 1,52 | +3,39% | 5,36% | 3.584.160 |
| 09/10/1974 | 1,39 | 1,47 | 1,37 | 1,47 | +5,73% | 7,40% | 3.086.150 |
| 08/10/1974 | 1,41 | 1,44 | 1,38 | 1,39 | -1,64% | 4,22% | 2.312.726 |
| 07/10/1974 | 1,36 | 1,42 | 1,36 | 1,41 | +4,41% | 4,88% | 1.335.571 |
| 04/10/1974 | 1,32 | 1,38 | 1,31 | 1,35 | +2,25% | 5,26% | 1.660.032 |
| 03/10/1974 | 1,33 | 1,35 | 1,31 | 1,32 | -0,50% | 3,24% | 1.184.659 |
| 02/10/1974 | 1,33 | 1,36 | 1,33 | 1,33 | +0,25% | 2,50% | 1.803.398 |
| 01/10/1974 | 1,33 | 1,35 | 1,28 | 1,33 | -0,50% | 4,98% | 4.138.762 |
| 30/09/1974 | 1,34 | 1,34 | 1,29 | 1,33 | -1,47% | 3,95% | 2.961.648 |
| 27/09/1974 | 1,42 | 1,43 | 1,35 | 1,35 | -5,12% | 5,81% | 3.248.381 |
| 26/09/1974 | 1,43 | 1,44 | 1,41 | 1,42 | -0,69% | 1,62% | 969.610 |
| 25/09/1974 | 1,43 | 1,50 | 1,41 | 1,43 | +0,46% | 6,27% | 2.422.138 |
| 24/09/1974 | 1,45 | 1,45 | 1,42 | 1,43 | -2,93% | 1,60% | 2.467.411 |
| 23/09/1974 | 1,50 | 1,50 | 1,47 | 1,47 | -3,69% | 2,20% | 1.369.526 |
| 20/09/1974 | 1,55 | 1,55 | 1,48 | 1,53 | -1,91% | 4,28% | 2.833.373 |
| 19/09/1974 | 1,52 | 1,57 | 1,52 | 1,56 | +4,91% | 3,26% | 2.667.370 |
| 18/09/1974 | 1,47 | 1,50 | 1,43 | 1,48 | +1,13% | 4,29% | 2.350.454 |
| 17/09/1974 | 1,40 | 1,53 | 1,40 | 1,47 | +7,00% | 8,73% | 2.410.819 |
| 16/09/1974 | 1,30 | 1,38 | 1,30 | 1,37 | +5,61% | 5,87% | 2.961.648 |
| 13/09/1974 | 1,31 | 1,31 | 1,24 | 1,30 | -6,44% | 5,57% | 6.715.584 |
| 12/09/1974 | 1,54 | 1,54 | 1,38 | 1,39 | -10,08% | 10,34% | 8.024.746 |
| 11/09/1974 | 1,55 | 1,57 | 1,54 | 1,54 | -0,43% | 2,14% | 1.011.110 |
| 10/09/1974 | 1,59 | 1,60 | 1,54 | 1,55 | -2,29% | 3,35% | 1.788.307 |
| 09/09/1974 | 1,64 | 1,64 | 1,58 | 1,59 | -3,43% | 4,03% | 1.441.210 |
| 06/09/1974 | 1,64 | 1,69 | 1,63 | 1,64 | +0,00% | 3,83% | 2.135.405 |
| 05/09/1974 | 1,60 | 1,66 | 1,58 | 1,64 | +2,90% | 4,98% | 1.263.888 |